Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jamjoom Pharmaceuticals Factory Co Days Payable Chart
SAU:4015 vs ZTS, UTHR, VTRS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Jamjoom Pharmaceuticals Factory Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jamjoom Pharmaceuticals Factory Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jamjoom Pharmaceuticals Factory Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Jamjoom Pharmaceuticals Factory Co's Days Payable falls into.
Jamjoom Pharmaceuticals Factory Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jamjoom Pharmaceuticals Factory Co (SAU:4015) has a Days Payable of 163.04 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Jamjoom Pharmaceuticals Factory Co and its competitors. This is 244% above median its historical median of 47.46. Over the past decade, Jamjoom Pharmaceuticals Factory Co's Days Payable has ranged from 24.95 to 145.96. According to the industry distribution chart, Jamjoom Pharmaceuticals Factory Co ranks #233 out of 924 companies in the Drug Manufacturers industry, placing it in the top 25.2%.
Is Jamjoom Pharmaceuticals Factory Co's Days Payable too high?
Jamjoom Pharmaceuticals Factory Co's current Days Payable of 163.04 is 244% above median its 10-year median of 47.46. Over the past 10 years, this metric has ranged from a low of 24.95 to a high of 145.96. The Drug Manufacturers industry median Days Payable is 88.80. Jamjoom Pharmaceuticals Factory Co's value of 163.04 is 83.6% above this industry median. Based on the distribution chart, Jamjoom Pharmaceuticals Factory Co ranks #233 out of 924 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Jamjoom Pharmaceuticals Factory Co has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jamjoom Pharmaceuticals Factory Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jamjoom Pharmaceuticals Factory Co ranks #233 out of 924 companies for Days Payable. This puts Jamjoom Pharmaceuticals Factory Co in the upper half of its industry. The industry median Days Payable is 88.80. Jamjoom Pharmaceuticals Factory Co's value of 163.04 is 83.6% above this benchmark. Historically, Jamjoom Pharmaceuticals Factory Co's own Days Payable has ranged from 24.95 to 145.96 over the past decade. While the company's 10-year median is 47.46 vs. the industry median of 88.80, Jamjoom Pharmaceuticals Factory Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 88.80, based on 924 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jamjoom Pharmaceuticals Factory Co's current Days Payable of 163.04 is 83.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Jamjoom Pharmaceuticals Factory Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 88.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jamjoom Pharmaceuticals Factory Co's current Days Payable is 163.04, which is 244% above median its own 10-year median of 47.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jamjoom Pharmaceuticals Factory Co stock overvalued right now?
Based on GuruFocus' analysis, Jamjoom Pharmaceuticals Factory Co (SAU:4015) is currently considered Modestly Undervalued. The stock's GF Value™ is ﷼179.99, compared to a current price of ﷼140.50 — trading 21.9% below its estimated fair value. The current Days Payable is 163.04, which is 244% above median its 10-year median of 47.46 and 83.6% above the Drug Manufacturers industry median of 88.80. Jamjoom Pharmaceuticals Factory Co's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Jamjoom Pharmaceuticals Factory Co (SAU:4015), the current Days Payable is 163.04 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jamjoom Pharmaceuticals Factory Co (SAU:4015) Overvalued in 2026?
Based on GuruFocus' analysis, Jamjoom Pharmaceuticals Factory Co stock appears to be undervalued.
The current stock price of ﷼140.50 is trading 21.9% below its estimated GF Value™ of ﷼179.99.
GuruFocus considers Jamjoom Pharmaceuticals Factory Co to be Modestly Undervalued.
Key valuation signals for SAU:4015:
Days Payable: 163.04 (244% above median its 10-year median of 47.46)
GF Value™: ﷼179.99 vs. price of ﷼140.50 (21.9% below fair value)
Industry Position: 83.6% above the Drug Manufacturers median (#233 of 924)
No single metric tells the full story. See the SAU:4015 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jamjoom Pharmaceuticals Factory Co is engaged in producing human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer and acidity, treatment of various skin infections, cancer diseases, eye drops and ointments and cosmeceuticals. Geographically the company has a presence in the Kingdom of Saudi Arabia, the Gulf, Iraq, Egypt, North Africa, and other export markets.
93GF Score
Get the complete analysis for SAU:4015
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4015 has been successfully added to your 
